Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 19Observational 2

Sponsor

Conditions

Breast Neoplasms 2936Neoplasms 2636Lung Neoplasms 1374Colorectal Neoplasms 1332Prostatic Neoplasms 1216Carcinoma, Non-Small-Cell Lung 1081Carcinoma, Hepatocellular 785Stomach Neoplasms 721Pancreatic Neoplasms 704Ovarian Neoplasms 586Colonic Neoplasms 534Uterine Cervical Neoplasms 497Head and Neck Neoplasms 497Rectal Neoplasms 472Melanoma 467Multiple Myeloma 464Esophageal Neoplasms 423Neoplasm Metastasis 418Brain Neoplasms 408Lymphoma 400Precursor Cell Lymphoblastic Leukemia-Lymphoma 399Urinary Bladder Neoplasms 387Leukemia, Myeloid, Acute 387Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 321Endometrial Neoplasms 319Hematologic Neoplasms 314Recurrence 299Disease 275

Interventions

pexidartinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Giant Cell Tumor of Tendon Sheath × Clear all
NCT07075471 2025-11-05

Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib

Deciphera Pharmaceuticals, LLC

Recruiting
100 enrolled

Giant Cell Tumor of Tendon Sheath

NCT04635111 2025-10-06

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIOâ„¢ (Pexidartinib) Treatment

Daiichi Sankyo

Recruiting
30 enrolled

Giant Cell Tumor of Tendon Sheath

Data powered by HemOnc (CC BY 4.0) Colophon âš¡